FDA’s PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell ...
FDA's PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIR ...
Vafseo® demonstrated a clinically meaningful safety outcome benefit in U.S. patients with anemia due to CKD on dialysis utilizing TIW dosing ...
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced the closing of its license agreement for VEPPANUTM ...
Most articles focus on liver disease, but doctors say your body also sends encouraging signals when your liver is functioning well. Here are the subtle signs that may indicate this vital organ is ...
Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder lacking a gold-standard diagnostic ...
Detailed price information for Tg Therapeutics (TGTX-Q) from The Globe and Mail including charting and trades.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
AST SpaceMobile suffered a set-back in May when a Blue Origin New Glenn rocket failed to reach its correct orbit and the AST satellite was lost and eventually deorbited. AST is hoping for a more ...
A simple formula developed at VCU two decades ago has become a global standard for liver disease detection, helping millions ...
CAPE CANAVERAL SPACE FORCE STATION — For those who woke up early on Thursday morning, they got to see SpaceX launch AST SpaceMobile’s five commercial satellites despite the weather not looking ...
AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It ...